Dubinsky MC, Schreiber S, Yarur AJ, Sands BE, et al. Recovery of response and long-term outcomes following loss of response and dose escalation of subcutaneous infliximab: a post hoc analysis of the LIBERTY-CD & LIBERTY-UC trials. Inflamm Bowel Dis 2026;32:1235-1247.
PMID: 41849243